Rapidly evolving brain neuroimaging techniques such as magnetic resonance i
maging (MRI) and positron emission tomography (PET) Eire proving fruitful i
n exploring the pathogenesis and pathophysiology of posttraumatic stress di
sorder (PTSD). Structural abnormalities in PTSD found with MRI include nons
pecific white matter lesions and decreased hippocampal volume. These abnorm
alities may reflect pretrauma vulnerability to develop PTSD, or they may be
a consequence of traumatic exposure, PTSD, and/or PTSD sequelae. Functiona
l neuroimaging symptom provocation and cognitive activation paradigms using
PET measurement of regional cerebral blood flow have revealed greater acti
vation of the amygdala and anterior paralimbic structures (which are known
to be involved in processing negative emotions such as fear), greater deact
ivation of Broca's region (motor speech) and other nonlimbic cortical regio
ns, and failure of activation of the cingulate cortex (which possibly plays
an inhibitory role) in response to trauma- related stimuli in individuals
with PTSD. Functional MRI research has shown the amygdala to be hyperrespon
sive to fear-related stimuli in this disorder. Research with PET suggests t
hat cortical, notably hippocampal, metabolism is suppressed to a greater ex
tent by pharmacologic stimulation of the noradrenergic system in persons wi
th PTSD. The growth of knowledge concerning the anatomical and neurochemica
l basis of this important mental disorder will hopefully eventually lead to
rational psychological and pharmacologic treatments.